Actavia Life Sciences, Inc.Actavia Life Sciences, Inc.Actavia Life Sciences, Inc.

Actavia Life Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪13.04 M‬USD
−0.0005USD
‪−4.44 M‬USD
‪113.77 M‬
Beta (1Y)
3.07

About Actavia Life Sciences, Inc.

Headquarters
New York
Employees (FY)
1
Website
Founded
2013
FIGI
BBG005846VL3
Actavia Life Sciences, Inc. is a biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. It also develops small molecule drug candidates that focus on treating acute myeloid leukemia. The company was founded in 2013 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RASP is 0.0169 USD — it has increased by 17.36% in the past 24 hours. Watch Actavia Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Actavia Life Sciences, Inc. stocks are traded under the ticker RASP.
RASP stock has risen by 35.20% compared to the previous week, the month change is a 111.25% rise, over the last year Actavia Life Sciences, Inc. has showed a 148.53% increase.
RASP reached its all-time high on Jan 3, 2018 with the price of 10.0000 USD, and its all-time low was 0.0001 USD and was reached on Apr 19, 2022. View more price dynamics on RASP chart.
See other stocks reaching their highest and lowest prices.
RASP stock is 14.79% volatile and has beta coefficient of 3.07. Track Actavia Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Actavia Life Sciences, Inc. there?
Today Actavia Life Sciences, Inc. has the market capitalization of ‪13.04 M‬, it has decreased by 27.75% over the last week.
Yes, you can track Actavia Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
RASP net income for the last quarter is ‪−95.52 K‬ USD, while the quarter before that showed ‪−147.64 K‬ USD of net income which accounts for 35.30% change. Track more Actavia Life Sciences, Inc. financial stats to get the full picture.
No, RASP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 1.00 employees. See our rating of the largest employees — is Actavia Life Sciences, Inc. on this list?
Like other stocks, RASP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Actavia Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Actavia Life Sciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Actavia Life Sciences, Inc. stock shows the neutral signal. See more of Actavia Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.